GlaxoSmithKline Pharmaceuticals (India) Alpha and Beta Analysis
| GLAXO Stock | 2,444 30.80 1.28% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as GlaxoSmithKline Pharmaceuticals Limited. It also helps investors analyze the systematic and unsystematic risks associated with investing in GlaxoSmithKline Pharmaceuticals over a specified time horizon. Remember, high GlaxoSmithKline Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to GlaxoSmithKline Pharmaceuticals' market risk premium analysis include:
Beta 0.43 | Alpha (0.30) | Risk 1.75 | Sharpe Ratio (0.12) | Expected Return (0.20) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
GlaxoSmithKline |
GlaxoSmithKline Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. GlaxoSmithKline Pharmaceuticals market risk premium is the additional return an investor will receive from holding GlaxoSmithKline Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in GlaxoSmithKline Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate GlaxoSmithKline Pharmaceuticals' performance over market.| α | -0.3 | β | 0.43 |
GlaxoSmithKline Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of GlaxoSmithKline Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how GlaxoSmithKline Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.GlaxoSmithKline Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how GlaxoSmithKline Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlaxoSmithKline Pharmaceuticals shares will generate the highest return on investment. By understating and applying GlaxoSmithKline Pharmaceuticals stock market price indicators, traders can identify GlaxoSmithKline Pharmaceuticals position entry and exit signals to maximize returns.
GlaxoSmithKline Pharmaceuticals Return and Market Media
The median price of GlaxoSmithKline Pharmaceuticals for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 2692.36 with a coefficient of variation of 5.27. The daily time series for the period is distributed with a sample standard deviation of 140.16, arithmetic mean of 2659.38, and mean deviation of 113.31. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | GSK Pharma stock gains over 3 percent after profit, revenue boost in Q2 earnings - Business Standard | 10/30/2024 |
2 | GlaxoSmithKline Pharmaceuticals - Negative Breakout 5 stocks cross below their 200 DMAs - The Economic Times | 11/18/2024 |
About GlaxoSmithKline Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including GlaxoSmithKline or other stocks. Alpha measures the amount that position in GlaxoSmithKline Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GlaxoSmithKline Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GlaxoSmithKline Pharmaceuticals' short interest history, or implied volatility extrapolated from GlaxoSmithKline Pharmaceuticals options trading.
Build Portfolio with GlaxoSmithKline Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in GlaxoSmithKline Stock
GlaxoSmithKline Pharmaceuticals financial ratios help investors to determine whether GlaxoSmithKline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GlaxoSmithKline with respect to the benefits of owning GlaxoSmithKline Pharmaceuticals security.